Total Payments
$1,484
2024 Payments
$703.26
Companies
11
Transactions
35
Medicare Patients
2,069
Medicare Billing
$111,284
Payment Breakdown by Category
Food & Beverage$1,252 (84.3%)
Other$232.49 (15.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,252 | 32 | 84.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $232.49 | 3 | 15.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $408.06 | 9 | $0 (2024) |
| Novo Nordisk Inc | $318.18 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $277.95 | 7 | $0 (2024) |
| Teleflex LLC | $145.20 | 1 | $0 (2024) |
| Lilly USA, LLC | $127.59 | 4 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $105.30 | 1 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $38.04 | 3 | $0 (2021) |
| GlaxoSmithKline, LLC. | $20.46 | 1 | $0 (2023) |
| Medtronic, Inc. | $18.55 | 1 | $0 (2024) |
| Boston Scientific Corporation | $13.14 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $703.26 | 13 | ABBVIE INC. ($379.98) |
| 2023 | $213.67 | 4 | Novo Nordisk Inc ($178.67) |
| 2022 | $306.13 | 4 | Novo Nordisk Inc ($109.34) |
| 2021 | $261.31 | 14 | AstraZeneca Pharmaceuticals LP ($161.73) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $47.87 | General |
| 10/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Diabetes | ||||||
| 10/07/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $176.00 | General |
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $116.22 | General |
| Category: Respiratory | ||||||
| 08/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $65.50 | General |
| Category: FACIAL AESTHETICS | ||||||
| 08/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $55.21 | General |
| Category: FACIAL AESTHETICS | ||||||
| 08/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: FACIAL AESTHETICS | ||||||
| 07/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.80 | General |
| Category: FACIAL AESTHETICS | ||||||
| 07/17/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 07/03/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $8.62 | General |
| 06/26/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: General - Pain Management_NMD | ||||||
| 04/10/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $145.20 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 05/23/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: RESPIRATORY | ||||||
| 05/04/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: NEUROSCIENCE | ||||||
| 04/20/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $94.01 | General |
| Category: Obesity | ||||||
| 01/26/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $84.66 | General |
| Category: Obesity | ||||||
| 10/13/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $42.94 | General |
| Category: Diabetes | ||||||
| 10/04/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $66.40 | General |
| Category: Obesity | ||||||
| 09/14/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $91.49 | General |
| Category: Diabetes | ||||||
| 02/23/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $105.30 | General |
| Category: PRIMARY CARE | ||||||
| 11/17/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2021 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: Diabetes | ||||||
| 10/27/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), TRIJARDY XR | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: DIABETES | ||||||
| 09/29/2021 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 653 | 761 | $88,512 | $37,529 |
| 2022 | 13 | 561 | 647 | $67,143 | $29,047 |
| 2021 | 12 | 579 | 721 | $71,860 | $33,672 |
| 2020 | 6 | 276 | 311 | $25,547 | $11,036 |
Total Patients
2,069
Total Services
2,440
Medicare Billing
$111,284
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 172 | 208 | $32,201 | $12,863 | 39.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 134 | 153 | $16,072 | $6,774 | 42.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 31 | 35 | $13,615 | $4,292 | 31.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 14 | 14 | $7,420 | $3,946 | 53.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 42 | 42 | $6,510 | $3,184 | 48.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 22 | 22 | $3,850 | $2,246 | 58.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 42 | 43 | $2,150 | $1,231 | 57.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 106 | 136 | $2,249 | $1,131 | 50.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 16 | 16 | $1,200 | $553.92 | 46.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 17 | 34 | $1,020 | $551.48 | 54.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 19 | 19 | $950.00 | $543.97 | 57.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 24 | 24 | $1,200 | $180.23 | 15.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 14 | 15 | $75.00 | $33.00 | 44.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 124 | 153 | $22,338 | $9,867 | 44.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 132 | 143 | $14,157 | $6,262 | 44.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 19 | 19 | $9,994 | $3,354 | 33.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 31 | 31 | $5,425 | $3,224 | 59.4% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 15 | 15 | $5,835 | $1,973 | 33.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 27 | 27 | $3,510 | $1,851 | 52.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 29 | 29 | $1,450 | $790.83 | 54.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 13 | 13 | $975.00 | $451.85 | 46.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 110 | 143 | $1,144 | $422.28 | 36.9% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 11 | 22 | $660.00 | $358.14 | 54.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 12 | 12 | $600.00 | $329.48 | 54.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 19 | 19 | $950.00 | $117.00 | 12.3% |
About Sarah Knoth
Sarah Knoth is a Family healthcare provider based in Muncie, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/28/2020. The National Provider Identifier (NPI) number assigned to this provider is 1083245088.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sarah Knoth has received a total of $1,484 in payments from pharmaceutical and medical device companies, with $703.26 received in 2024. These payments were reported across 35 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,252).
As a Medicare-enrolled provider, Knoth has provided services to 2,069 Medicare beneficiaries, totaling 2,440 services with total Medicare billing of $111,284. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Muncie, IN
- Active Since 01/28/2020
- Last Updated 03/23/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1083245088
Products in Payments
- Wegovy (Drug) $178.67
- BOTOX (Biological) $147.49
- UROLIFT (Device) $145.20
- NURTEC ODT (Drug) $143.34
- AIRSUPRA (Drug) $116.22
- FARXIGA (Drug) $99.47
- MOUNJARO (Drug) $91.49
- Saxenda (Drug) $66.40
- JARDIANCE (Drug) $48.00
- Rybelsus (Drug) $42.94
- Ozempic (Drug) $30.17
- AREXVY (Drug) $20.46
- INTELLIS ADAPTIVESTIM (Device) $18.55
- VRAYLAR (Drug) $14.54
- QULIPTA (Drug) $13.54
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Muncie
Abby Koons, Np, NP
Family — Payments: $4,731
Family $4,731
Lara Mote, Fnp, FNP
Family — Payments: $3,388
Family $3,388
Mrs. Natalie Main, Fnp-C, FNP-C
Family — Payments: $2,989
Family $2,989
Lisa Dornick, Arnp, ARNP
Family — Payments: $2,830
Family $2,830
Brandy Lopilato, Apn, APN
Family — Payments: $2,711
Family $2,711
Katy Cool, Np, NP
Family — Payments: $2,640
Family $2,640